Search

everythinglearnresearchcommunity

for

Search:↓

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.